These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 14722344)

  • 1. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors.
    Prather PL
    Sci STKE; 2004 Jan; 2004(215):pe1. PubMed ID: 14722344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of inverse agonism in a G protein-coupled receptor.
    Vilardaga JP; Steinmeyer R; Harms GS; Lohse MJ
    Nat Chem Biol; 2005 Jun; 1(1):25-8. PubMed ID: 16407989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.
    Seifert R; Wenzel-Seifert K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):381-416. PubMed ID: 12382069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective.
    Milligan G
    Mol Pharmacol; 2003 Dec; 64(6):1271-6. PubMed ID: 14645655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
    Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse agonist activity of selected ligands of platelet-activating factor receptor.
    Dupré DJ; Le Gouill C; Rola-Pleszczynski M; Stanková J
    J Pharmacol Exp Ther; 2001 Oct; 299(1):358-65. PubMed ID: 11561099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptors: a count of 1001 conformations.
    Vauquelin G; Van Liefde I
    Fundam Clin Pharmacol; 2005 Feb; 19(1):45-56. PubMed ID: 15660959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance.
    Bosier B; Hermans E
    Trends Pharmacol Sci; 2007 Aug; 28(8):438-46. PubMed ID: 17629964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of G protein-coupled receptors.
    Deupi X; Kobilka B
    Adv Protein Chem; 2007; 74():137-66. PubMed ID: 17854657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-specific receptor states: implications for opiate receptor signalling and regulation.
    Piñeyro G; Archer-Lahlou E
    Cell Signal; 2007 Jan; 19(1):8-19. PubMed ID: 16842969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse agonism: more than reverting constitutively active receptor signaling.
    Dupré DJ; Rola-Pleszczynski M; Stanková J
    Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
    Hudson BD; Hébert TE; Kelly ME
    Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of conformational ensembles of seven transmembrane receptors in functional selectivity.
    Vaidehi N; Kenakin T
    Curr Opin Pharmacol; 2010 Dec; 10(6):775-81. PubMed ID: 20933468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement of 'gating charge' is coupled to ligand binding in a G-protein-coupled receptor.
    Ben-Chaim Y; Chanda B; Dascal N; Bezanilla F; Parnas I; Parnas H
    Nature; 2006 Nov; 444(7115):106-9. PubMed ID: 17065983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.
    Gilchrist A
    Trends Pharmacol Sci; 2007 Aug; 28(8):431-7. PubMed ID: 17644194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.